Screening for lung cancer: The guidelines Review uri icon

Overview

MeSH Major

  • Lung Neoplasms
  • Mass Screening

abstract

  • Although virtually all individuals with advanced lung cancer succumb to the disease, a substantial portion of individuals diagnosed at an earlier stage can be cured. This dichotomy has provoked interest in lung cancer screening. To date, randomized controlled trials of chest x-ray and sputum cytology have failed to demonstrate that screening with either modality decreases lung cancer mortality; neither of these technologies can be recommended. Early studies of lung cancer screening with low-dose CT (LDCT) appear promising; however, only data from observational studies are available. We recommend that individuals should only be screened with LDCT in the context of well-designed clinical trials.

publication date

  • February 4, 2003

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 12527567

Additional Document Info

start page

  • 83S

end page

  • 88S

volume

  • 123

number

  • 1 SUPPL.